FR
NL
EN

HOME
/
CASES
/
HEMAR

Inspiring Cases

Overview CBHC ATMP

07 may 2024

Cross-border Healthcare for advanced therapies

Bol2 PROJECT JUIST formaat

02 february 2023

Cost study, HE support and P&R dossier for radiopharmaceutical product for treatment of adult GEP-NET patients in Belgium

Bol2 PROJECT JUIST formaat

14 december 2022

Cross-border healthcare in ATMPs

Bol2 fitness be

25 january 2022

The potential health and economic impact of gym usage in Belgium

28 october 2021

Budget impact analysis of filgotinib for treatment of rheumatoid arthritis in Belgium

06 september 2021

Health economic analysis of erenumab for treatment of migraine in Belgium

17 september 2020

PRISMA: Towards personalized medicine for Alzheimer

06 june 2019

Health economic evaluation: Prophylactic use of Enterol for prevention of antibiotics-associated diarrhea in hospitalized patients

10 september 2019

Engaging stakeholders on Price & Reimbursement of Orphan Medicinal Products and Innovative Therapies

10 september 2019

Health economic analyses of a CAR T-cell therapy for the treatment of pALL patients in Belgium

06 june 2019

Health & budget impact of combined HIV prevention & value based pricing of integrated care for HIV patients

06 june 2019

Health economic analyses of a CAR T-cell therapy for the treatment of DLBCL patients in Belgium

06 june 2019

Health economic analysis of Rydapt for treatment of AML patients in Belgium

06 june 2019

Cost-effectiveness model and report for Jakavi in the treatment of patients with Myelofibrosis in Belgium

07 june 2019

Budget impact analysis second class reimbursement submission of injectable long-acting schizophrenia maintenance treatment drug in Belgium.

1
2

Interested in our client-driven approach?

How can we help optimising your business?

CTA Formula Footer